Adial Pharmaceuticals, Inc. Proceeds from Sale of Productive Assets
Adial Pharmaceuticals, Inc. (ADIL) reported Proceeds from Sale of Productive Assets of $1.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2025-03-04
- Adial Pharmaceuticals, Inc. proceeds from sale of productive assets for the quarter ending 2023-12-31 was $350.00K.
- Adial Pharmaceuticals, Inc. proceeds from sale of productive assets for the quarter ending 2023-09-30 was $350.00K.
- Adial Pharmaceuticals, Inc. proceeds from sale of productive assets for fiscal 2023 was $1.50M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $700.00K derived: sum of 2 quarters · filed 2025-03-04 | $1.50M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.15M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $800.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |